PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Jan-2026 ALST Signs Non-Disclosure Agreement with Major Toronto University for Proposed Allstar Sports Centre Development ACCESS Newswire
06-Jan-2026 LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington’s Disease LoQus23 Therapeutics
06-Jan-2026 HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma HUTCHMED
06-Jan-2026 Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging Biotium
06-Jan-2026 Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation Acesion Pharma
06-Jan-2026 Ikarovec to Advance Pipeline With Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology Businesswire
06-Jan-2026 MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy* GSK
06-Jan-2026 Companion Diagnostics Market Research Report 2026 | Analysis, Size, Share and Forecast to 2031 Medi-Tech Insights
06-Jan-2026 Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium Businesswire
06-Jan-2026 Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is expected to extend asset exclusivity in EU into 2044 Newron
06-Jan-2026 Iksuda to present preliminary analysis of oesophageal cancer data from Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium Iksuda
06-Jan-2026 Medical Care Technologies Inc. (OTC Pink:MDCE) Announces Attendance at CES 2026 in Las Vegas ACCESS Newswire
06-Jan-2026 Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities Galapagos
06-Jan-2026 TeleTracking Appoints Derek Ritchea as Chief Strategy Officer ACCESS Newswire
06-Jan-2026 TeleTracking Appoints Derek Ritchea as Chief Strategy Officer ACCESS Newswire
06-Jan-2026 XVIVO's CEO to present at J.P. Morgan's 44th Annual Healthcare Conference in San Francisco ACCESS Newswire
06-Jan-2026 Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication ACCESS Newswire
06-Jan-2026 MDaudit Expands Executive Team ACCESS Newswire
06-Jan-2026 LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington’s Disease LoQus23 Therapeutics
06-Jan-2026 Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation Acesion Pharma